- Home
- OABI vs DGICB Comparison
OABI vs DGICB Comparison
Compare OABI & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- DGICB
- Stock Information
- Founded
- OABI 2012
- DGICB 1986
- Country
- OABI United States
- DGICB United States
- Employees
- OABI N/A
- DGICB N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- DGICB Property-Casualty Insurers
- Sector
- OABI Health Care
- DGICB Finance
- Exchange
- OABI Nasdaq
- DGICB Nasdaq
- Market Cap
- OABI 459.1M
- DGICB 431.9M
- IPO Year
- OABI N/A
- DGICB N/A
- Fundamental
- Price
- OABI $4.53
- DGICB $13.74
- Analyst Decision
- OABI Strong Buy
- DGICB
- Analyst Count
- OABI 4
- DGICB 0
- Target Price
- OABI $9.00
- DGICB N/A
- AVG Volume (30 Days)
- OABI 349.2K
- DGICB 332.0
- Earning Date
- OABI 11-12-2024
- DGICB 10-24-2024
- Dividend Yield
- OABI N/A
- DGICB 4.65%
- EPS Growth
- OABI N/A
- DGICB 148.60
- EPS
- OABI N/A
- DGICB 0.74
- Revenue
- OABI $21,714,000.00
- DGICB $979,118,984.00
- Revenue This Year
- OABI N/A
- DGICB N/A
- Revenue Next Year
- OABI $71.78
- DGICB $6.66
- P/E Ratio
- OABI N/A
- DGICB $20.96
- Revenue Growth
- OABI N/A
- DGICB 7.44
- 52 Week Low
- OABI $3.56
- DGICB $10.75
- 52 Week High
- OABI $6.72
- DGICB $16.00
- Technical
- Relative Strength Index (RSI)
- OABI 73.77
- DGICB 50.77
- Support Level
- OABI $4.04
- DGICB $13.34
- Resistance Level
- OABI $4.87
- DGICB $14.88
- Average True Range (ATR)
- OABI 0.18
- DGICB 0.18
- MACD
- OABI 0.10
- DGICB -0.03
- Stochastic Oscillator
- OABI 86.09
- DGICB 49.78
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.